Evidence map›Paper›PMID 26504514›Full record

ArticleSkeletal muscle2015

Pax3-induced expansion enables the genetic correction of dystrophic satellite cells.

Antonio Filareto, Fabrizio Rinaldi, Robert W Arpke, Radbod Darabi, Joseph J Belanto, Erik A Toso, Auston Z Miller, James M Ervasti, R Scott McIvor, Michael Kyba and 1 more

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Stem cell therapy for muscular dystrophies.The Journal of clinical investigation · 2020
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Antonio Filareto *Department of Medicine, Lillehei Heart Institute, University of Minnesota, 4-128 CCRB, 2231 6th St. SE, Minneapolis, MN 55455 USA.
Fabrizio Rinaldi *Department of Medicine, Lillehei Heart Institute, University of Minnesota, 4-128 CCRB, 2231 6th St. SE, Minneapolis, MN 55455 USA.
Robert W ArpkeDepartment of Pediatrics, Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455 USA.
Radbod DarabiDepartment of Medicine, Lillehei Heart Institute, University of Minnesota, 4-128 CCRB, 2231 6th St. SE, Minneapolis, MN 55455 USA.
Joseph J BelantoDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455 USA.
Erik A TosoDepartment of Pediatrics, Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455 USA.
Auston Z MillerDepartment of Medicine, Lillehei Heart Institute, University of Minnesota, 4-128 CCRB, 2231 6th St. SE, Minneapolis, MN 55455 USA.
James M ErvastiDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455 USA.
R Scott McIvorDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455 USA.
Michael KybaDepartment of Pediatrics, Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455 USA.
Rita Cr PerlingeiroDepartment of Medicine, Lillehei Heart Institute, University of Minnesota, 4-128 CCRB, 2231 6th St. SE, Minneapolis, MN 55455 USA.
University of Minnesota · USMinneapolis Heart Institute Foundation · US

Funding

TRAINING PROGRAM IN MUSCLE RESEARCHT32AR007612 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JAMES M ERVASTI, DAWN A LOWE · 2001 to 2026
$11.3M
CYTOSKELETAL INTERACTIONS OF DYSTROPHINR01AR042423 · NIAMS · UNIVERSITY OF WISCONSIN MADISON · PI ERVASTI, JAMES M · 1994 to 2025
$9.3M
Probing the Activity of DUX4 in FSHDR01AR055685 · NIAMS · UNIVERSITY OF MINNESOTA · PI Michael Kyba · 2010 to 2026
$7.0M
Skeletal Muscle Regeneration from Differentiating Pluripotent Stem CellsR01AR055299 · NIAMS · UNIVERSITY OF MINNESOTA · PI PERLINGEIRO, RITA C. R. · 2008 to 2018
$3.3M
FSHD iPS Cells: Genetic Correction and MyogenesisR01NS083549 · NINDS · UNIVERSITY OF MINNESOTA · PI KYBA, MICHAEL · 2013 to 2017
$1.7M
Examining the Therapeutic Potential of iPS cells in Duchenne Muscular DystrophyRC1AR058118 · NIAMS · UNIVERSITY OF MINNESOTA · PI PERLINGEIRO, RITA C. R. · 2010 to 2010
$1000k
Skeletal Muscle Regeneration from Pluripotent Stem CellsR56AR055299 · NIAMS · UNIVERSITY OF MINNESOTA · PI PERLINGEIRO, RITA C. R. · 2020 to 2020
$424k
Tools to study age-related changes in muscle stem cellsR21AG034370 · NIA · UNIVERSITY OF MINNESOTA · PI KYBA, MICHAEL · 2009 to 2010
$413k
NIAMS NIH HHS R01 AR042423NIAMS NIH HHS R01 AR055299NIAMS NIH HHS R01 AR055685NIAMS NIH HHS R56 AR055299NIAMS NIH HHS RC1 AR058118NIAMS NIH HHS T32 AR007612NIA NIH HHS R21 AG034370NINDS NIH HHS R01 NS083549
6 · The paper itself

Abstract

backgroundSatellite cells (SCs) are indispensable for muscle regeneration and repair; however, due to low frequency in primary muscle and loss of engraftment potential after ex vivo expansion, their use in cell therapy is currently unfeasible. To date, an alternative to this limitation has been the transplantation of SC-derived myogenic progenitor cells (MPCs), although these do not hold the same attractive properties of stem cells, such as self-renewal and long-term regenerative potential.

methodsWe develop a method to expand wild-type and dystrophic fresh isolated satellite cells using transient expression of Pax3. This approach can be combined with genetic correction of dystrophic satellite cells and utilized to promote muscle regeneration when transplanted into dystrophic mice.

resultsHere, we show that SCs from wild-type and dystrophic mice can be expanded in culture through transient expression of Pax3, and these expanded activated SCs can regenerate the muscle. We test this approach in a gene therapy model by correcting dystrophic SCs from a mouse lacking dystrophin using a Sleeping Beauty transposon carrying the human μDYSTROPHIN gene. Transplantation of these expanded corrected cells into immune-deficient, dystrophin-deficient mice generated large numbers of dystrophin-expressing myofibers and improved contractile strength. Importantly, in vitro expanded SCs engrafted the SC compartment and could regenerate muscle after secondary injury.

conclusionThese results demonstrate that Pax3 is able to promote the ex vivo expansion of SCs while maintaining their stem cell regenerative properties.

Indexed as

DystrophinGene correctionMuscular dystrophyPax3RegenerationSatellite cellsSleeping Beauty

Identifiers

PMID26504514
PMCPMC4620645
OpenAlexW1827213206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.